Global Nucleic Acid Isolation & Purification Market Growth, Trends & Forecasts 2017 - 2022

  • ID: 4387385
  • Report
  • Region: Global
  • 206 pages
  • Mordor Intelligence
1 of 3
The Global market for Nucleic Acid Isolation & Purification is poised to reach $XX million by 2020 growing at a CAGR of XX%. Every gene manipulation procedure requires genetic material like DNA and RNA. Nucleic acids occur naturally in association with proteins and lipoprotein organelles.

The dissociation of a nucleoprotein into nucleic acid and protein moieties and their subsequent separation, are the essential steps in the isolation of all species of nucleic acids. Isolation of nucleic acids is followed by quantitation of nucleic acids generally done by either spectrophotometric or by using fluorescent dyes to determine the average concentrations and purity of DNA or RNA present in a mixture.Currently, North America dominates the global market followed by Europe. APAC is the fastest growing segment. The Global Nucleic Acid Isolation & Purification market can be segmented on the basis of technology (Column based, Magnetic bead based & Reagent based purification), Product (Consumables, Reagents, and Equipment), Application (RNA & DNA sequencing, RNA & DNA cloning, DNA electrophoresis, transcriptome analysis), End users (Academia, Hospitals, Biotechnology, Pharmaceuticals, CRO) and Geography (North America, Europe, APAC & RoW)DriversRapid technological advances, wide range applications of nucleic acid and rise in the R&D funding for biotechnology and healthcare boosting the market growth.RestraintsLow penetration of emerging market and market on the verge of saturation making it difficult for new market players restraining the growth of the market.Key Deliverables in the Study

Market Definition for the specified topic along with identification of key drivers and restraints for the market. Market analysis for the Global Nucleic Acid Isolation & Purification Market, with region specific assessments and competition analysis on a global and regional scale. Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.Identification and analysis of the Macro and Micro factors that affect the Global Nucleic Acid Isolation & Purification market on both global and regional scale.
Note: Product cover images may vary from those shown
2 of 3
1.1 Study deliveratives
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and forecasr period years
1.6 General Study Assumptions
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric forecast models
2.4 Research Assumptions
5.1 Current market scenario
5.2 Technology Overview
5.3 New developments in therapeutics
5.4 Investment analysis
5.5 Porters Five Force Analysis
5.5.1 Bargaining Power of suppliers
5.5.2 Bargaining power of buyers
5.5.3 Degree of competition
5.5.4 Threat of substitution
5.5.5 Threat of new entrants
6.1 Market Drivers
6.1.1 Rising demand for miminally invasive procedures
6.1.2 Upsurge of Peripheral vascular diseases
6.1.3 Lifestyle changes and increase in the ageing population
6.1.4 Technological advancements
6.2 Market Restraints
6.2.1 Stringent Regulatory Framework
6.2.2 Reimbursement issues
6.2.3 Highly fragmented market
6.3 Market Opportunities
6.3.1 Growing use of bio-absorbable stents
6.3.2 Rise in health awareness and increasing expendable earnings
6.4 Key Challenges
6.4.1 Cost of the procedure especially in the developing countries
6.4.2 Product failures have been reported by many small players
7. Global peripheral vascular device market Segmentation
7.1 Angioplasty Balloons
7.1.1 Based on product Normal balloon Cutting balloon Scoring balloon Drug coated balloon
7.1.2 Based on material used Non-Compliant Balloons Semi-Compliant Balloons
7.2 Stents
7.2.1 Ballon expandable stent
7.2.2 Self expandable stents
7.2.3 Covered stents
7.3 Embolic Protection devices
7.4 Inferior Vena Cava filters
7.5 Aortic Stent Grafts
7.6 Synthetic Surgical Grafts
7.7 Peripheral Vascular Accessory Devices
7.8 PTA Balloon Catheters
7.9 Vascular Closure Devices
7.10 Chronic Total Occlusion (CTO) Devices
7.11 Others
8. Global peripheral vascular device market Georaphy - Regional shares and forecast
8.1 North America
8.1.1 Introduction
8.1.2 USA
8.1.3 Canada
8.1.4 Mexico
8.1.5 Rest of North America
8.2 Europe
8.2.1 Introduction
8.2.2 France
8.2.3 UK
8.2.4 Germany
8.2.5 Spain and Portugal
8.2.6 Italy
8.2.7 Scandinavia
8.2.9 Rest of Europe
8.3 Asia-Pacific
8.3.1 Introduction
8.3.2 India
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 Australia and New Zealand
8.3.7 Rest of Asia Pacific
8.4 Middle East and Africa
8.4.1 Introduction
8.4.2 GCC
8.4.3 Egypt
8.4.4 Rest of Middle East and Africa
8.5 Latin America
8.5.1 Introduction
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Rest of Latin America COMPETITIVE LANDSCAPE
10. Abbott Laboratories
10.1 Angioscore
10.2 Boston Scientific Corporation
10.3 C.R.Bard, Inc.
10.4 Bayer AG
10.5 Biosensors International Group
10.6 Covidien PLC
10.7 Emboline INC
10.8 Ednologix
10.9 Lombard Medical Technologies Plc
10.10 Analyst outlook for Investment Opportunities
11. Future outlook of the market
13. Abbrevations
13.1 Bibliography
13.2 Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown